RE:RE:RE:RE:RE:RE:RE:RE:CG Oncology NMIBC dataVery much agree enriquesuave although even that 6 month 2nd treatment could be in question as with monthly checkups each patient should be determined as still CR or needing another treatment. Who knows some may require second treatment at 4 months while others could go years before the 2nd!
enriquesuave wrote On top of our best in class single agent data so far, the fact that this a pretty much a One and Done treatment and see you in 6 months for a maintenance should be used to push the FDA for BTD. Needs of Elderly patients must be taken into account. This option gives them freedom and much less morbidity of having weekly instillations with all of the swelling and pain and possible infections which the procedure involves. IMHO
ScienceFirst wrote:
_______________
There has been innovations in all industries, including oncology. And this wil continue. No plot theories here. Just facts, R&D, innovations and competition.
Public Health budgets are about 50% of all Canadian provinces budgets. So huge incentives to lower them, especially with the growing population of elderly people. Ontario government that sponsored our technology that will spur medical tourism will of course push for such treatment if deemed superior.
Private insurance companies are other parties that will push for it too.
Laparoscopy, arteoscopy, 1-day surgeries, etc ... are all innovative procedures that have been integrated in the health systems. TLT has done the heavy lifting to bring PDT/PDC to bedside and mainstream thanks to a molecule with impressive attributes. It could allow big pharmas to treat way more patients in early stage instead of having too many dying because of lack of efficient treatments.